Dow Up 0.08% Nasdaq Down 0.30%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
161.44 0.12(0.07%) Sep 19, 4:00PM EDT
Prev Close:161.56
Open:162.80
Bid:140.00 x 100
Ask:N/A
1y Target Est:198.65
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:159.28 - 163.50
52wk Range:100.89 - 185.43
Volume:3,092,096
Avg Vol (3m):1,185,110
Market Cap:31.94B
P/E (ttm):97.61
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 0.07%31.94B
AMGN109.39B
BAX39.29B

Key Statistics

Forward P/E (1 yr):28.08
P/S (ttm):16.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback